Robotic Technology Transforming Therapeutic GI
Easy, Accurate and Safe
Endoscopic Removal of Complex Lesions
The Need
En-bloc removal of gastrointestinal polyps is a cornerstone of colorectal and gastric cancer treatment and a crucial preventative measure, safeguarding against potential malignancies while improving overall GI health.
Traditional approaches require an additional visit after the initial screening examination, leading to increased healthcare expenses, added complexity, and challenge patient compliance issues.
Current alternatives have substantial faults:
Open or laparoscopic procedures
Major operations that are highly invasive, complex, and expensive, with significant patient risks.
EMR
(Endoscopic Mucosal Resection)
Is often incomplete for flat or large lesions, preventing margin assessment and potentially increasing the risk of malignant cell spread.
ESD
(Endoscopic Submucosal Dissection)
Technically demanding, requiring extensive training, and posing elevated complications risk, such as bleeding and perforations, requiring careful intraoperative management.
Open or laparoscopic procedures
Major operations that are highly invasive, complex, and expensive, with significant patient risks.
EMR
(Endoscopic Mucosal Resection)
Is often incomplete for flat or large lesions, preventing margin assessment and potentially increasing the risk of malignant cell spread.
ESD
(Endoscopic Submucosal Dissection)
Technically demanding, requiring extensive training, and posing elevated complications risk, such as bleeding and perforations, requiring careful intraoperative management.
Our Solution
MicroSteer delivers a breakthrough solution for the removal of complex lesions within the gastrointestinal tract, offering significant advantages for both patients and healthcare providers. Designed for seamless integration, the device attaches to most commercially available colonoscopes and gastroscopes and operates with standard off-the-shelf tools. Its precise, automated control enables accurate dissection and facilitates complete en-bloc tissue removal, ensuring optimal histopathological analysis and improved clinical outcomes.
Easy to Master
Streamline the procedure, making it intuitive and straightforward, far easier to learn and master than ESD.
Improved Efficacy
Robotic precision and automated control enables precise dissection, ensuring complete en-bloc tissue removal for reliable histopathological analysis.
Enhanced Safety
Precise control of the cutting tool minimizes unintentional movements, significantly reduces the risk of perforation, improving patient safety.
Cost Savings
Shorten lesion removal time and procedure duration. The option to combine the procedure with the screening colonoscopy may further save time, reduce healthcare costs and optimize resources.
We’re setting a new standard in endoscopic care –
Simplifying access to complex medical techniques , efficient and safe for both patients and providers.
About
MicroSteer is addressing a critical need in gastrointestinal care of intraoperative removal of complex lesions.
MicroSteer is developing a novel, semi-automated technology designed for complex polypectomies traditionally associated with EMR (Endoscopic Mucosal Resection) and ESD (Endoscopic Submucosal Dissection). MicroSteer’s introduces the first steered polypectomy device, empowering endoscopists to perform safer and faster procedures, that were previously limited to highly experienced interventional gastroenterologists. The system facilitates variable range of adjustable cutting devices guided along a pre-defined, programmed exact track – delivering unmatched precision, efficiency, and confidence in en-bloc tissue removal.
Management Team
Ofer Pillar
Eyal Ben-Esti
Adi Strauss
Scientific Advisory Board
Dr. Amyn Haji
- Consultant Colorectal & Laparoscopic
- Surgeon at King’s College Hospital, London
- Lead for Complex Polyps and Early Cancer
Prof. Shivangi Kothari
- Associate Professor of Medicine and Associate Director of Endoscopy at the University of Rochester Medical Center
- 2024 ACG Governor's Service Award for contributions to gastroenterology.
Prof. Ken Ohata
- Chief Gastroenterology and Director of the Endoscopy Center at NTT, Medical Center Tokyo
- Over 15 years of ESD experience and ~3,500 procedures performed
Dr. Ari Benson
- Director of Endoscopy Unit, Shaare Zedek Medical Center
- Fellowship in Advanced Endoscopy, Hadassah Medical Center
- ESD training in Kobe, Japan
Dr. Sergei Vosko
- Director of Endoscopy Unit, Hadassah Medical Center
- Founder of the Advanced Endoscopic Resection Unit at Shamir Medical Center
- Training in Advanced Endoscopy in Westamide Hospital, Sydney
Intellectual Property
MicroSteer is dedicated to protecting its intellectual property, actively seeking patent protection across major global markets. The products and patent numbers listed below represent a substantial portion of our portfolio though they do not include all pending or granted patents. We continue to advance additional patents that are currently under review. For further details on granted patents and published U.S. patent applications, please visit the United States Patent and Trademark Office website. Published international patent applications may be viewed at the World Intellectual Property Organization website.
EP4061256A1, US12426907, JP7741557
These patents describe a medical device that assists endoscopist access and treat raised tissues, such as polyps or tumors. It works by placing a special rail near the targeted tissue inside the body. A small robotic vehicle, carrying surgical tools like a cutter, moves along this rail, allowing doctors to reach and operate different sides of the tissue without needing to reposition their instruments manually. This approach aims to make procedures less invasive, safer and more accurate, improving outcomes for patients.
News
6-March-2025
MicroSteer Receives European Patent Allowance for Innovative Polypectomy Technology
MicroSteer is proud to announce that the European Patent Office has issued a Notice of Allowance for one of our core patents, marking a significant step in securing protection of our groundbreaking technology for endoscopic polyp removal. This strengthens MicroSteer’s intellectual property portfolio and reinforces our commitment to revolutionizing minimally invasive endoscopic procedures across Europe. The allowance paves the way for broader adoption of our advanced solutions, empowering clinicians and improving patient outcomes in digestive health.
4-Apr-2025
MicroSteer Earns 3rd Place in Fan Favorite at 2025 AGA Tech Summit Shark Tank!
MicroSteer is proud to announce its remarkable achievement at the 2025 AGA Tech Summit Shark Tank in Chicago. As a finalist in this prestigious event, our CEO, Eyal Ben Esti, delivered a compelling presentation of our groundbreaking technology aimed at transforming endoscopic polypectomy. The presentation captivated both the esteemed panel and the live audience, earning MicroSteer 3rd place in the Fan Favorite category! This recognition highlights the transformative potential of our innovation in enhancing patient care and redefine the future of polyp removal procedures.
20-Aug-2025
EndoEdison 2025 Finalist – FIESTA by ASGE
MicroSteer was selected as a finalist in the EndoEdison 2025 competition, part of FIESTA – the Festival of Innovation in Endoscopy and Technology organized by the American Society for Gastrointestinal Endoscopy (ASGE). This recognition underscores MicroSteer’s leadership at the forefront of endoscopic innovation for complex lesion management and shaping the future of minimally invasive care.
9-Sep-2025
Japan Patent Granted
MicroSteer is proud to announce that we have been granted a Japanese patent (#7741557) for our innovative robotic platform for complex GI lesion removal. This milestone expands our IP coverage in one of the world’s leading markets for endoscopy and medical devices. This protection strengthens our foundation for
future clinical and commercial collaborations across the Asia–Pacific region, reinforcing our commitment to advancing minimally invasive solutions for complex gastrointestinal procedures.
11-Sep-2025
MicroSteer Secures IIA Seed Grant
MicroSteer secured a Seed grant from the Israel Innovation Authority, providing non-dilutive funding to accelerate development and validation of its robotic endoscopic platform. This support strengthens our ability to advance toward clinical trials and regulatory clearances.
30-Sep-2025
US Patent Granted
MicroSteer secured a United States patent (US 12,426,907) protecting its core robotic endoscopy technology, strengthening the company’s intellectual property position in one of the world’s largest healthcare markets. This patent provides long-term strategic protection as MicroSteer advances toward clinical and commercial deployment.
1-Oct-2025
HealthTech Forward 2025 – Wild X Finalist, Barcelona
MicroSteer reached the finalist stage in the Wild X category at the HealthTech Forward 2025 startup competition in Barcelona. This recognition positions MicroSteer among Europe’s most promising healthtech startups shaping the future of minimally invasive care.
9-Oct-2025
HealthTech Forum, Bucharest – 1st place
MicroSteer was awarded first place at the HealthTech Forum startup competition in Bucharest, recognizing the company’s innovative approach to transforming complex polyp removal. This international award underscores MicroSteer’s clinical impact and market potential in the rapidly evolving field of GI robotics.
12-Nov-2025
MicroSteer at the 2025 King’s Live ESD Course
MicroSteer was honored to participate in the King’s Live ESD course led by Dr. Amyn Haji at King’s College Hospital in London. During this training, gastroenterologists had the opportunity to observe and perform first-hand complex lesion removal using MicroSteer’s robotic technology. This hands-on experience demonstrated how our system can enhance control, precision, and accessibility in advanced endoscopic procedures.
18-Nov-2025
MEDICA Startup Competition – TOP 15
MicroSteer was ranked in the TOP 15 at the MEDICA Startup Competition in November 2025, selected from a pool of 230 international applicants. Being shortlisted at MEDICA, one of the world’s leading medtech platforms, reflects the strong global interest in MicroSteer’s robotic endoscopy solution and its potential to transform complex gastrointestinal procedures